首页 正文

Trabectedin-irinotecan as a potential therapeutic option in desmoplastic small round cell tumor: A small case series

{{output}}
IntroductionDesmoplastic small round cell tumor (DSRCT) is a rare and aggressive mesenchymal malignancy driven by the EWS-WT1 gene fusion. Prognosis remains poor despite intensive multimodal therapy. Preclinical studies indicate that trabectedin combined with ... ...